Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
Drug repurposing is the use of known drugs for new indications. Malignant pleural mesothelioma (MPM) is a rare cancer with a poor prognosis. So far, few treatments have been approved in this disease. However, its incidence is expected to increase significantly, particularly in developing countries....
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2018-03-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/27/147/170098.full |